Education
About Us
Working with TipRanks
Follow Us
Carolyn R Bertozzi Insider Profile
4 Followers
Carolyn R Bertozzi, Director at Eli Lilly & Co, holds 93.31K shares in OmniAb (Ticker: OABI), holds 775.00 shares in Alnylam Pharma (Ticker: ALNY), holds 6.24K shares in Eli Lilly & Co (Ticker: LLY).
Carolyn R Bertozzi has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Carolyn R Bertozzi holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Carolyn R Bertozzi
Carolyn R Bertozzi's Trading History
Eli Lilly & Co
Nov 18, 2020
Director
Uninformative Buy
175.03K
$5.66M
OmniAb
Nov 03, 2025
Director
Uninformative Buy
27.54K
$163.29K
Alnylam Pharma
May 12, 2025
Director
Uninformative Buy
―
$241.93K
List of latest transactions for each holding click on a transaction to see Carolyn R Bertozzi's performance on stock
You May Also Like
Carolyn R Bertozzi insider profile FAQ
What is the percentage of profitable transactions made by Carolyn R Bertozzi?
The percentage of profitable transactions made by Carolyn R Bertozzi is ―.
What is the average return per transaction made by Carolyn R Bertozzi?
The average return per transaction made by Carolyn R Bertozzi is ―.
What stocks does Carolyn R Bertozzi hold?
Carolyn R Bertozzi holds: LLY, OABI, ALNY stocks.
What was Carolyn R Bertozzi’s latest transaction?
Carolyn R Bertozzi latest transaction was an Uninformative Buy of $27.54K.
What was Carolyn R Bertozzi's most profitable transaction?
Carolyn R Bertozzi’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Carolyn R Bertozzi's role in Eli Lilly & Co?
Carolyn R Bertozzi's role in Eli Lilly & Co is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.